Wayne, New Jersey -- Maquet Cardiovascular announced 16 March that it has received European CE Mark approval for its Fusion Bioline Vascular Graft, for use in patients with peripheral artery disease (PAD).
Unlike traditional vascular grafts that use a single material, the Fusion Vascular Graft is a synthetic graft constructed of two layers -- an inner layer comprised of extruded, expanded polytetrafluoroethylene (ePTFE) and an outer layer comprised of a PET knit polyester textile.
These two layers are fused together with a proprietary polycarbonate-urethane adhesive. This unique two-layer construction delivers patient benefits both during and after surgery, including axial compliance for better handling compared with standard ePTFE grafts; high suture retention strength and durability for long-term performance; and minimal suture hole bleeding for improved hemostasis.
"
